Related Experiment Video
Updated: May 22, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
The immunoregulatory function of vitamin D: implications in chronic kidney disease
Kevin A Sterling1, Parham Eftekhari, Matthias Girndt
1Division of Renal Diseases and Hypertension, Department of Medicine, The George Washington University School of Medicine, 2150 Pennsylvania Avenue NW, Washington, DC 20037, USA.
Insights
Vitamin D deficiency in chronic kidney disease (CKD) patients contributes to immune dysfunction and increased mortality. Supplementation may reduce infection risk and improve survival, but optimal preparations require further study.
Area of Science:
- Nephrology
- Immunology
- Endocrinology
Background:
- Cardiovascular and infectious diseases are leading causes of death in chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients.
- Vitamin D plays a crucial role in cardiovascular health and immune system regulation, maintaining inflammatory balance.
- Patients with CKD and ESRD exhibit decreased levels of both inactive (25-hydroxyvitamin D) and active (1,25-dihydroxyvitamin D) vitamin D.
Purpose of the Study:
- To explore the hypothesis that vitamin D deficiency contributes to immune dysfunction and heightened infection susceptibility in CKD/ESRD patients.
- To review evidence linking vitamin D deficiency to increased mortality in ESRD.
- To assess the potential benefits of vitamin D treatment on infection risk and mortality in this population.
Main Methods:
- Review of basic science and epidemiological studies.
- Analysis of observational data on vitamin D levels and clinical outcomes in ESRD patients.
- Discussion of the current understanding of vitamin D's immune regulatory functions.
Main Results:
- Observational studies associate vitamin D deficiency in ESRD with higher mortality.
- Vitamin D treatment in ESRD patients has been linked to reduced infection risk and all-cause mortality.
- The differential effects of various vitamin D preparations on patient outcomes remain unclear.
Conclusions:
- Immune dysfunction in CKD/ESRD patients may be partly explained by vitamin D deficiency.
- Vitamin D supplementation shows promise for improving outcomes in CKD/ESRD patients.
- Further research is needed to determine the optimal vitamin D preparations for therapeutic use in kidney disease.
Abstract:
Cardiovascular and infectious diseases remain the most common causes of death among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Basic science and epidemiological studies indicate that vitamin D has importance not only for cardiovascular health, but also for the immune response. Vitamin D signaling pathways regulate both innate and adaptive immunity, maintaining the associated inflammatory response within physiological limits. Levels of both the inactive as well as active form of vitamin D (25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, respectively) are decreased in patients with CKD and ESRD. It is reasonable to hypothesize, therefore, that the immune dysfunction associated with vitamin D deficiency in patients with CKD and ESRD in part explains the misdirected inflammatory response and increased susceptibility to infection seen in this population. Indeed, observational studies show that vitamin D deficiency in patients with ESRD is associated with increased mortality, and treatment with vitamin D is associated with a decreased risk of infection, as well as reduced all-cause mortality. However, whether different vitamin D preparations have differential effects on physiological function and clinical outcomes is still unclear. A proper understanding of the immune regulatory function of vitamin D is important for the development of future therapeutic strategies.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology
